1. Home
  2. RGNX vs MBVI Comparison

RGNX vs MBVI Comparison

Compare RGNX & MBVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$7.26

Market Cap

487.2M

Sector

Health Care

ML Signal

N/A

Logo M3-Brigade Acquisition VI Corp. Class A Ordinary Shares

MBVI

M3-Brigade Acquisition VI Corp. Class A Ordinary Shares

N/A

Current Price

$10.30

Market Cap

443.3M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
RGNX
MBVI
Founded
2008
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
487.2M
443.3M
IPO Year
2015
2025

Fundamental Metrics

Financial Performance
Metric
RGNX
MBVI
Price
$7.26
$10.30
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $21.40
N/A
AVG Volume (30 Days)
★ 1.1M
65.2K
Earning Date
11-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 18.08
N/A
EPS
N/A
★ N/A
Revenue
★ $10,393,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$24.01
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 126.48
N/A
52 Week Low
$5.46
$9.99
52 Week High
$16.19
$10.36

Technical Indicators

Market Signals
Indicator
RGNX
MBVI
Relative Strength Index (RSI) 44.73 70.79
Support Level $6.79 $10.23
Resistance Level $7.32 N/A
Average True Range (ATR) 0.59 0.01
MACD -0.03 0.00
Stochastic Oscillator 15.40 45.45

Price Performance

Historical Comparison
RGNX
MBVI

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

About MBVI M3-Brigade Acquisition VI Corp. Class A Ordinary Shares

M3-Brigade Acquisition VI Corp is a newly incorporated blank check company.

Share on Social Networks: